ReleaseWire Connect

An investor in shares of Imation Corp. (NYSE:IMN) filed a lawsuit against certain directors of Imation Corp over alleged breaches of fiduciary duties in connection with the compensation of certain executives.

A deadline is coming up on April 17, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of JBI Inc (OTC: JBII) between August 28, 2009 and January 4, 2012.

An investigation on behalf of investors of Magnachip Semiconductor Corp (NYSE:MX) shares over potential securities laws violations by Magnachip Semiconductor and certain of its directors and officers in connection certain financial statements was announced.

A deadline is coming up on February 27, 2015 in the lawsuit filed for investors of RCS Capital Corp (NYSE:RCAP) over alleged Violations of Federal Securities Laws by RCS Capital Corp.

A deadline is coming up on February 23, 2015 in the lawsuit filed for investors of Roka Bioscience Inc (NASDAQ:ROKA) over alleged Securities Laws Violations by Roka Bioscience.

An investor, who purchased shares of Xoom Corp (NASDAQ:XOOM), filed a lawsuit in the Superior Court of the State of California for the County of San Francisco over alleged violations of Federal Securities Laws by Xoom Corp in connection with the initial public offering conducted on February 14, 2013.

An investor, who currently holds shares of Hospira, Inc. (NYSE:HSP), filed a lawsuit in effort to halt the proposed takeover of Hospira, Inc. by Pfizer Inc.

An investigation on behalf of current long-term investors in shares of Imation Corp. (NYSE:IMN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Imation in connection with compensation paid to certain executives.

An investigation on behalf of investors of CTPartners Executive Search Inc (NYSEMKT:CTP) shares over potential securities laws violations by CTPartners Executive Search and certain of its directors and officers in connection certain financial statements was announced.

An investigation on behalf of current long-term investors in shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) concerning potential breaches of fiduciary duties by certain directors and officers of Sarepta Therapeutics Inc was announced.